Evotec/Spero Deal Extended For Gram-negative Bacteria

Evotec AGEVTCY announced that it has extended its existing collaboration agreement with Spero Therapeutics for the development of new and ground breaking therapeutics for Gram negative bacteria. The collaboration aims at discovering and developing Gram negative bacteria for the